In insulin-resistant conditions, such as diabetes, the trafficking of GLUT4-containing vesicles is impaired [6], and the increase in GLUT4 expression and/or its translocation to the cell surface is a primary target in the treatment of diabetes [7,8]. This evidence concerns the gene INS and diabetes mellitus.